John P. Berdahl
NEW YORK — Since its commercial rollout in July, the Light Adjustable Lens has been implanted in 18 sites across the country, offering surgeons simplified preoperative messaging and decision-making and delivering better vision for patients, according to a speaker here.
“This is the first lens that can be customized after cataract surgery. It simplifies the messaging and the decision-making because I really don’t have to worry about what’s going on with the posterior cornea, I don’t have to worry about effective lens position, and I don’t have to worry about surgery-induced astigmatism,” John P. Berdahl, MD, said at OSN New York 2019.
The Light Adjustable Lens (RxSight), designated as a premium IOL by CMS, has received excellent patient acceptance since its rollout and has captured between 30% to 50% of premium procedures in participating practices. The lens pricing is typically 1.5 times more than what is charged for a toric lens.
The lens is a “truly disruptive” technology, differing from traditional cataract surgery and disruptive to a clinic’s flow. Patients must be brought back after 3 weeks, adjusted on day 1, adjusted again 2 days later and locked in 2 days later, Berdahl said.
Light Adjustable Lens monovision, if the distance eye is accurate and the near eye is successfully adjusted to its target, is comparable to trifocality or multifocality, he said.
“I don’t use toric lenses anymore unless there is a reason because the pupil doesn’t dilate enough or they’re on photosensitizing medication. We get fabulous outcomes, and we can treat up to 4 D of astigmatism, probably, with multiple treatments,” Berdahl said. – by Robert Linnehan
Berdahl JP. Where are we today with the Light Adjustable Lens? Presented at: OSN New York 2019; Nov. 15-17, 2019; New York.
Disclosure: Berdahl reports he is a consultant for RxSight.